P. Fidias
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 7
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 4
-
- Lung Cancer Treatments and Mutations 22
- Gastric Cancer Management and Outcomes 13
- Lung Cancer Diagnosis and Treatment 8
-
- Cancer Genomics and Diagnostics 4
- Otorhinolaryngology top 10%
- Gastroenterology top 10%
-
- Esophageal Cancer Research and Treatment 5
- Co-authors
- Chandra P. BelaniE. KaukelA PłużańskaRodryg RamlauMichael MillwardJoachim von PawelFrank V. FossellaK. Mattson
- Partner nations
- United StatesAustriaJapan
In The Last Decade
P. Fidias
38 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 882
- Pulmonary and Respiratory Medicine 971
- Cancer Research 116
- Otorhinolaryngology 26
- Gastroenterology 31
Countries citing papers authored by P. Fidias
This map shows the geographic impact of P. Fidias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Fidias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Fidias more than expected).
Fields of papers citing papers by P. Fidias
This network shows the impact of papers produced by P. Fidias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Fidias. The network helps show where P. Fidias may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Fidias, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2017 | 3 | |
| 3 | 2016 | 2 | |
| 4 | 2014 | 12 | |
| 5 | 2014 | 1 | |
| 6 | 2012 | 17 | |
| 7 | 2011 | 35 | |
| 8 | 2011 | 38 | |
| 9 | 2011 | 83 | |
| 10 | 2011 | 4 | |
| 11 | 2010 | 1 | |
| 12 | 2009 | 16 | |
| 13 | 2008 | 36 | |
| 14 | 2006 | 39 | |
| 15 | 2005 | 15 | |
| 16 | 2005 | 1 | |
| 17 | 2005 | 2 | |
| 18 | 2005 | 6 | |
| 19 | 2005 | 2 | |
| 20 | Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Groupbreakdown → | 2003 | 763 |
About P. Fidias
P. Fidias is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Gastric Cancer Management and Outcomes (13 papers), Lung Cancer Diagnosis and Treatment (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Research Studies (6 papers), Esophageal Cancer Research and Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (882 citations), Pulmonary and Respiratory Medicine (971 citations) and Cancer Research (116 citations). P. Fidias has collaborated with scholars based in United States, Austria and Japan. Frequent co-authors include Chandra P. Belani, E. Kaukel, A Płużańska, Rodryg Ramlau, Michael Millward, Joachim von Pawel, Frank V. Fossella, K. Mattson, Aleksandra Szczęsna and Jose R. Pereira. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.